ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,398, issued on Oct. 27, was assigned to Xyra LLC (Los Altos, Calif.).
"Formulations of crystalline budiodarone Form-1" was invented by Pascal Druzgala (Santa Rosa, Calif.) and Cyrus Becker (Pleasanton, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided here is a composition comprising a stable, flowable, agglomeration-resistant, granular composition of a crystalline salt of budiodarone. Also provided are methods of manufacturing such stable, flowable, agglomeration-resistant granular compositions."
The patent was filed on Nov. 7, 2025, under Application No. 19/382,796.
*For further information, including images, charts and tables, plea...